Brandywine Pharmaceuticals recalls

Brandywine Pharmaceuticals has 2 recalls on record with the FDA and USDA, the earliest in 2026 and the latest reported on 4 Nov 2026. 2 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls2since 2026

Last 12 months2reported

Class I00% of total

Ongoing2latest 4 Nov 2026

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 2

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why brandywine pharmaceuticals is recalled

Potency & Assay2100%

By year

20262100%

Ongoing brandywine pharmaceuticals recalls

2 active

Reported	Class	Recall	Company	Reason	Where
4 Nov 2026Drug	CLASS II	Theophylline Extended-Release Tablets, 200 mg recalled	Brandywine Pharmaceuticals	Potency & Assay	Nationwide
4 Nov 2026Drug	CLASS II	Theophylline Extended-Release Tablets, 100 mg recalled	Brandywine Pharmaceuticals	Potency & Assay	Nationwide

All brandywine pharmaceuticals recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
4 Nov 2026Drug	CLASS II	Theophylline Extended-Release Tablets, 200 mg recalled	Brandywine Pharmaceuticals	Potency & Assay	Nationwide
4 Nov 2026Drug	CLASS II	Theophylline Extended-Release Tablets, 100 mg recalled	Brandywine Pharmaceuticals	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.